October 4, 2012

PREDICT helps pinpoint right statin for patient

When O.T. Hayes, 67, of Lebanon, Tenn., first starting seeing his cardiologist, David Hansen, M.D., for treatment of his coronary artery disease, it was hard to predict which of the various medications available would help control Haynes’ high cholesterol.

By Kathy Whitney

July 19, 2012

Research makes case for prospective genotyping

Vanderbilt researchers are investigating the potential benefits of prospective genetic testing for drug safety.

By Paul Govern

October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

By Craig Boerner